FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017635268> ?p ?o ?g. }

• W2017635268 endingPage "1662" @default.
• W2017635268 startingPage "1657" @default.
• W2017635268 abstract "Genetically modifying tumor cells to express a variety of cytokines such as interleukin-2 (IL-2) or the co-stimulatory molecule B7.1 leads to increased immunogenicity and reduced tumorigenicity of tumors in several models with T cells involved in the process. We have previously reported decreased tumorigenicity of the murine plasmacytoma J558L [major histocompatibility complex (MHC) class I+ and class II−] expressing IL-2 or B7.1. When systemic immunity was analyzed, immunization with either J558-IL2 or J558-B7.1 cells generated moderate protection against unmodified J558L tumor cells, comparable to immunization with a tumor cells/adjuvant Corynebacterium parvum mixture. In this study, we asked whether the co-expression of IL-2 and B7.1 in tumor cells would augment vaccine potency, cytotoxic T lymphocyte (CTL) activity and protective immunity. Rejection of single IL-2 or B7.1 or co-transfected IL-2/B7.1 cells occurred in most syngeneic animals but not in T cell-deficient nude mice, thus confirming that T cells were required for tumor rejection. We knew from previous experiments that CD8+ T cells were responsible for rejection. Surprisingly, immunization with J558-IL2/B7.1 cells followed by challenge with parental J558L caused a reduction in systemic protection as compared to J558-B7.1 or J558-IL2 alone. We examined the mechanism underlying this unexpected result: 6 days after injection of J558-IL2/B7.1 cells, tumor were nearly completely destroyed and were almost devoid of CD8+ cells, while CD8+ cells were increased in both IL-2- and B7.1-transfected tumors. In addition, immunization with J558-IL2/B7.1 tumors had an adverse effect on the generation of CTL. Mice immunized with J558-B7.1 and to a lesser extent J558-IL2 cells mounted a CTL response against J558L cells while, in contrast, no CTL activity could be detected in mice immunized with J558-IL2/B7.1, thus showing a correlation between the absence of CTL activity and the lack of in vivo protection. We demonstrate that “hyperstimulation” of the immune response by genetically modified cancer vaccines can have adverse effects on tumor immunity, even though the mechanism is not yet completely understood." @default.
• W2017635268 created "2016-06-24" @default.
• W2017635268 creator A5005434602 @default.
• W2017635268 creator A5008811301 @default.
• W2017635268 creator A5013866174 @default.
• W2017635268 creator A5030959848 @default.
• W2017635268 creator A5034157963 @default.
• W2017635268 creator A5040347320 @default.
• W2017635268 creator A5055709085 @default.
• W2017635268 creator A5086465315 @default.
• W2017635268 date "1997-07-01" @default.
• W2017635268 modified "2023-10-16" @default.
• W2017635268 title "Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency" @default.
• W2017635268 cites W1773381788 @default.
• W2017635268 cites W1963576366 @default.
• W2017635268 cites W1968266972 @default.
• W2017635268 cites W1978416272 @default.
• W2017635268 cites W1990668606 @default.
• W2017635268 cites W1991148746 @default.
• W2017635268 cites W2003411005 @default.
• W2017635268 cites W2004281948 @default.
• W2017635268 cites W2007035782 @default.
• W2017635268 cites W2017304478 @default.
• W2017635268 cites W2034335920 @default.
• W2017635268 cites W2059483129 @default.
• W2017635268 cites W2083331853 @default.
• W2017635268 cites W2092312916 @default.
• W2017635268 cites W2103684299 @default.
• W2017635268 cites W2104484006 @default.
• W2017635268 cites W2132519862 @default.
• W2017635268 cites W2134677648 @default.
• W2017635268 cites W2140066663 @default.
• W2017635268 cites W2149120449 @default.
• W2017635268 cites W2166192944 @default.
• W2017635268 cites W2169388007 @default.
• W2017635268 cites W4254092143 @default.
• W2017635268 doi "https://doi.org/10.1002/eji.1830270710" @default.
• W2017635268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9247574" @default.
• W2017635268 hasPublicationYear "1997" @default.
• W2017635268 type Work @default.
• W2017635268 sameAs 2017635268 @default.
• W2017635268 citedByCount "15" @default.
• W2017635268 countsByYear W20176352682012 @default.
• W2017635268 crossrefType "journal-article" @default.
• W2017635268 hasAuthorship W2017635268A5005434602 @default.
• W2017635268 hasAuthorship W2017635268A5008811301 @default.
• W2017635268 hasAuthorship W2017635268A5013866174 @default.
• W2017635268 hasAuthorship W2017635268A5030959848 @default.
• W2017635268 hasAuthorship W2017635268A5034157963 @default.
• W2017635268 hasAuthorship W2017635268A5040347320 @default.
• W2017635268 hasAuthorship W2017635268A5055709085 @default.
• W2017635268 hasAuthorship W2017635268A5086465315 @default.
• W2017635268 hasConcept C147969180 @default.
• W2017635268 hasConcept C154317977 @default.
• W2017635268 hasConcept C167672396 @default.
• W2017635268 hasConcept C202751555 @default.
• W2017635268 hasConcept C203014093 @default.
• W2017635268 hasConcept C207936829 @default.
• W2017635268 hasConcept C2776090121 @default.
• W2017635268 hasConcept C2777371288 @default.
• W2017635268 hasConcept C2780801004 @default.
• W2017635268 hasConcept C2780868878 @default.
• W2017635268 hasConcept C2992881475 @default.
• W2017635268 hasConcept C55493867 @default.
• W2017635268 hasConcept C86803240 @default.
• W2017635268 hasConcept C8891405 @default.
• W2017635268 hasConceptScore W2017635268C147969180 @default.
• W2017635268 hasConceptScore W2017635268C154317977 @default.
• W2017635268 hasConceptScore W2017635268C167672396 @default.
• W2017635268 hasConceptScore W2017635268C202751555 @default.
• W2017635268 hasConceptScore W2017635268C203014093 @default.
• W2017635268 hasConceptScore W2017635268C207936829 @default.
• W2017635268 hasConceptScore W2017635268C2776090121 @default.
• W2017635268 hasConceptScore W2017635268C2777371288 @default.
• W2017635268 hasConceptScore W2017635268C2780801004 @default.
• W2017635268 hasConceptScore W2017635268C2780868878 @default.
• W2017635268 hasConceptScore W2017635268C2992881475 @default.
• W2017635268 hasConceptScore W2017635268C55493867 @default.
• W2017635268 hasConceptScore W2017635268C86803240 @default.
• W2017635268 hasConceptScore W2017635268C8891405 @default.
• W2017635268 hasIssue "7" @default.
• W2017635268 hasLocation W20176352681 @default.
• W2017635268 hasLocation W20176352682 @default.
• W2017635268 hasOpenAccess W2017635268 @default.
• W2017635268 hasPrimaryLocation W20176352681 @default.
• W2017635268 hasRelatedWork W1542207790 @default.
• W2017635268 hasRelatedWork W1543217242 @default.
• W2017635268 hasRelatedWork W1912608743 @default.
• W2017635268 hasRelatedWork W1968531180 @default.
• W2017635268 hasRelatedWork W1999858178 @default.
• W2017635268 hasRelatedWork W2009411842 @default.
• W2017635268 hasRelatedWork W2123544686 @default.
• W2017635268 hasRelatedWork W2395122846 @default.
• W2017635268 hasRelatedWork W2992138720 @default.
• W2017635268 hasRelatedWork W2184553692 @default.
• W2017635268 hasVolume "27" @default.
• W2017635268 isParatext "false" @default.
• W2017635268 isRetracted "false" @default.

• next